We choose two additional sites that are of significant interest in correcting sickle cell disease (SCD) through the activation of fetal hemoglobin by targeting the BCL11A repressor motif in the HBB locus18 or GATA signal for erythroid-specific repression of BCL11A19. Here, BCL11A is linked to sickle cell disease.